Figure 3 | Scientific Reports

Figure 3

From: Cost-effectiveness Analysis of Fluorouracil, Leucovorin, and Irinotecan versus Epirubicin, Cisplatin, and Capecitabine in Patients with Advanced Gastric Adenocarcinoma

Figure 3

Tornado diagram of one-way sensitivity analysis.

Tornado diagram summarized the results of one-way sensitivity analysis to identify model variables associated with the two strategies in the treatment of advanced gastric cancer. The influential factors were listed descending with the variation of value. ECX, epirubicin, cisplatin, and capecitabine; FOLFIRI, fluorouracil, leucovorin, andirinotecan; AE, adverse event; K, a thousand times; pPD_death_ECX, transition probability for PD state to death in ECX arm;pPFS_death_ECX, transition probability for PFS state to death in ECX arm; pPFS_PD_ECX,transition probability for PFS state to PD state in ECX arm; pPD_death_FOLFIRI, transition probability for PD state to death in FOLFIRI arm; pPFS_death_FOLFIRI, transition probability for PFS state to death in FOLFIRI arm; pPFS_PD_FOLFIRI, transition probability for PFS state to PD state in FOLFIRI arm; cFOLFIRI, FOLFIRI cost; cSupportive_FOLFIRI, supportive cost in FOLFIRI arm; cECX, cost for ECX; cSupportive_ECX, cost for supportive drugs for ECX arm.

Back to article page